Autolus Therapeutics (AUTL) Current Assets: 2017-2025
Historic Current Assets for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to $514.6 million.
- Autolus Therapeutics' Current Assets fell 28.34% to $514.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.6 million, marking a year-over-year decrease of 28.34%. This contributed to the annual value of $660.9 million for FY2024, which is 140.07% up from last year.
- Latest data reveals that Autolus Therapeutics reported Current Assets of $514.6 million as of Q3 2025, which was down 10.39% from $574.2 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Current Assets high stood at $804.3 million for Q1 2024, and its period low was $212.3 million during Q3 2022.
- In the last 3 years, Autolus Therapeutics' Current Assets had a median value of $574.2 million in 2025 and averaged $543.6 million.
- In the last 5 years, Autolus Therapeutics' Current Assets surged by 11,539.24% in 2021 and then tumbled by 35.34% in 2023.
- Quarterly analysis of 5 years shows Autolus Therapeutics' Current Assets stood at $347.0 million in 2021, then rose by 22.72% to $425.8 million in 2022, then plummeted by 35.34% to $275.3 million in 2023, then skyrocketed by 140.07% to $660.9 million in 2024, then declined by 28.34% to $514.6 million in 2025.
- Its last three reported values are $514.6 million in Q3 2025, $574.2 million for Q2 2025, and $615.8 million during Q1 2025.